chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms began in the afternoon on Monday, July 12 around 2:00-3:00pm. I began experiencing numbness and tingling in right arm all the way from injection site through my right hand. Numbness has been strong enough at times over the last day or two to disrupt my daily routine. I began having a sharp pain in my chest that hasn?t subsided since the onset. This caused difficulty sleeping and the pain has been strong enough to be a distraction throughout the day. I am not experiencing any shortness of breath, but there is a strong tightness in chest.   Something to note:  I also experienced a similar numbness in left arm after first vaccine (06/17/21 EW0181) which I assumed was related to my Complex Regional Pain Syndrome (CRPS). I had a full headache for a couple weeks following this dose but no chest pain.
Patient received influenza vaccination on 10/31/12 in the left arm. Product was from Novartis, Lot #123203 (exp 6/2013). Patient developed myalgia, weakness and musculature cramping shortly after receiving the vaccination. He was not taking any other medications or received any other vaccinations other than annual influenza vaccination. The symptoms progressed over two week period after vaccination. These symptoms persist and only slightly improved after receiving a course of high dose prednisone prescribed by his local MD. Unfortunately the symptoms returned shortly after stopping the prednisone treatment. The local MD also determined slight thyroid dysfunction and synthroid supplementation was initiated. Myalgia and weakness have improved some but still persist.
She received  a pneumovax vaccine on 12-05-01. She developed some erythema over lying the area of her shot that has continued to spread. she talked to her doctor who started her on Keflex house the cellulitis has continued to spread so she came to ER: received neficillin.
PT has tonic clonic seizure within 5 min of immunization lasting for 1 min. Pt was evaluated with CT head to r/o any intracranial mass; which was WNL.
2 weeks after the vaccination, 03/20/2021- cramping around the injection,  shooting pain and I could not lift my arm, and could not lift my arm to take a shower, and I also could not focus clearly. Then I  went to the  doctor, I had tenderness under my armpit. The  doctor put me on leave for 4-5 days. After 5 days I had to return to work but I had to do limited work.  Dr. did do movements on my arm and that's when knew this was the cause of the vaccine. He put me on physical therapy, from May through August.
Regular period started on June 8th. Period lasted for 3 weeks after receiving vaccine. She then started her period again June 28th. Periods have been heavier than normal with increased cramping.
Mom reports onset of rash 3 days post varicella vaccine. Lesion noted 1st on face and progressed to entire body. Pt had around 30 lesions. Lesions are mostly maculo-papular. Few lesion on extremities have vesicles. No puritis, temp, or irritability with lesions. Advised conservative measures as follow up.
vaccine administered 0900 with report of "warmness" around and in mouth area 0904. 25mg Benadryl given PO.
Pt recvd vax JUN92 & devel burning sensation upon inject as well as soreness & or an aching sensation in the arm; heaviness in the arm also;
pt c/o tingling in mouth, lips, throat approx 5 minutes post injection.
Delayed urticaria hive like rash, generalized over body. Lasting in certain spots from 30 minutes to an hour at a time. Symptom relief with antihistamines. Was placed on prednisone 60mg x 5 days. Steroids helped but symptoms came back after I stopped taking them.  Currently still taking Zyrtec
Started to ache at site of administration a week later. 1st flu shot ever received. Pain increased to elbow, and tingling in fingers.
I had immediate arm pain and felt like pins sticking my arm all the way down to my hand.  The next day  nausea started and by the evening I had stomach cramps, nausea, and felt like I had COVID all over again whIch I had in December.  I felt better the next day but the nausea continued.  The shot site kept increasing in size and getting redder.  By Sunday afternoon I noticed a rash appearing on both of my arms and on my hands.  I immediately started using anti-itch creme we had bought for my husband when he had COVID.  It didn't help the rash got worse and  I went to my doctor on 3/31 and they prescribed prednisone for many days, Pepsid at night, and Hydroxyzine Hcl 25 mg. for itching.  Photos are available.
swelling, reddness, tenderness-itching-upper arm to elbow; pt referred to MD s/s dec on 14AUG95;
overall minor body aches after second dose; This is a spontaneous report from a contactable consumer. A 18-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 12Apr2021 at 09:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 9:30 as a single dose. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 10:00, the patient experienced overall minor body aches after the second dose. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event overall minor body aches was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient presented with a no health hx except for hives to PCN as a child and "passed out" with a childhood vaccine x 7 years ago.  Vaccine given without incident, doctor present to distract patient while I gave vaccine.  3-5 min post vaccine patient c/o of nausea and trash can provided.  Patient became silent while talking, head fell forward and clonic tonic  posturing noted in upper extremities.  Called to doctor and patient lowered to floor and placed in recovery position, MSE lasted approximately 30 seconds, EMS called. Post seizure: Patient very pale and diaphoretic, oriented to person quickly, no signs of facial swelling, resp distress or symptoms of a severe allergic reaction.    B/P 134/50 HR 80 and regular, patient at this time shares that he had a MSE 3 or 4 years ago with friends.  States came around after eating and drinking.   States he did not share this information with his health care provider. Patient was AA&O x3  but with dismissed LOC from pre-vaccine state. 1200-EMS arrived, B/P 110/7, glucose 88/EMS, attempted to sit patient up/EMS, became dizzy and pale.   Lowered to recovery position and waited for second team.   Attempted to sit patient up again when second team arrived and again he became pale and dizzy.   1212- patient consented to be transported to hospital at this time/EMS.
pt screamed for 24 hrs became very hyperactive & pt would not sleep; no fever was on APAP q 4 hrs; MD instructed to go to ER-however visit not made;
Started with symptoms similar to sinus infection. Stuffy nose, headache.  Turned in to extreme  spasms at base of neck/brain stem on 5/7.  Telehealth visit diagnosis was Sinus Infection, given a Z-Pack. 5/8 pain was better throughout the day. Later in the evening pain worsened. 5/9 pain was severe. Continued with Z-pack and Tylenol and Advil. 5/10 pain was a 15 on scale of 1-10. Went to ER, blood pressure was extremely high and a cough had developed. Upon triage patient did not have a fever. After CT was done and was clear fever was checked and it was 102.3. Spinal Tap was performed and chest X-rays and bloodwork. Patient admitted to hospital for four days.  Later diagnosed with double pneumonia, sepsis and viral meningitis. The Spinal Tap came back as borderline. Doctors felt the results were skewed due to Z-Pack.
Granuloma annulare. This rash got worse after every dose of Moderna. It is now disseminated granuloma annulare covering both arms, neck, head, shoulders, and back
Information has been received from a registered nurse concerning a patient at an elementary school who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient developed a mild case of breakthrough varicella. There was no product quality complaint involved. Additional information has been requested.
Past lot that had also been expired administered to patient; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired administered to patient) and NO ADVERSE EVENT (No adverse event) in a 66-year-old female patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired administered to patient) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired administered to patient).    NDCID number was reported as 80777027398. Patient age was reported as 66 years and 08 months. Concomitant product use was not provided by the reporter. It was reported that also another lot of vaccines lot number 065F21A was also expired and administered to patient and lot number O70H21A was administered to patient between 08-Apr-2022 and 15-Dec-2022. Treatment information was not provided.
MUSCLE PAIN IN BOTH LEGS, HIPS, NECK AND BOTH ARMS; NAUSEA; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol use. The patient had no known allergies. The patient had no history of drug abuse/illicit drug use. The patient was not pregnant at the time of reporting. The patient was non-smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 26-MAR-2021 14:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 27-MAR-2021, the subject experienced muscle pain in both legs, hips, neck and both arms. On 27-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea on 27-MAR-2021, and had not recovered from muscle pain in both legs, hips, neck and both arms. This report was non-serious.
A report has been received from a Health Professional concerning an 8 year old, Male subject, who had been receiving Nasal FLUMIST QUADRIVALENT for WHEEZING. A PATIENT WHO CAME IN FOR BREATHING TREATMENT DUE TO ACTIVELY WHEEZING RECEIVED FLUMIST QUADRIVALENT BY MISTAKE. FLUMIST WAS INTENDED FOR ANOTHER PATIENT. FLUMIST QUADRIVALENT started on 02-Nov-2013 for WHEEZING. The patient experienced RECEIVED FLUMIST QUADRIVALENT BY MISTAKE which started on 02-Nov-2013. The outcome of the event of RECEIVED FLUMIST QUADRIVALENT BY MISTAKE is unknown. The report was considered to be non-serious by the reporter.
dramatic swelling of the site w/ redness and pain same day as vaccine. pain, swelling slowly resolved over few days. No respiratory  complaints or dyspnea, some mild cough. no urinary complaints.  He feels tired  now. No fever reported - feeling better today.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Fever-Mild
devel fever Friday PM-t102 woke up Sat AM screaming was having hallucinations; APAP given;
chills, body aches after second dose; chills, body aches after second dose; This is a spontaneous report from a contactable consumer, patient. A 49-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0168) via an unspecified route of administration in the left arm on 15Apr2021(at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient did not have any known allergies to food, medication or other product.  The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep6955) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07May2021 at 16:00, the patient experienced chills, body aches after second dose. There were no symptoms after first dose. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills and body ache were recovered on unknown date in 2021 at the time of this report.  No follow-up attempts are needed. No further information is expected.
Large rash at injection site roughly the size of an oblong 3 3 inches diameter raised, red uniform rash (not spotty).  Today on 3/30/2021 it looks much bigger.  Now it?s all the way down to his inside elbow, very red (about 6 inches).  It looks very big and I?m concerned it?s infected.  He does not currently have a fever nor is it warm to touch.   We may call doctor later to ask about it.
Information has been received from a lawyer regarding a case in litigation concerning a male patient. The patient's age, medical history and concurrent conditions were not provided. On or about 29-JUL-2016 the patient was vaccinated with ZOSTAVAX,(route unknown) at a Health Center, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 15-APR-2016, the patient was treated by a Physician Assistant for a vesicular outbreak that was diagnosed as severe shingles. The patient was treated again on 02-JUN-2016 by a physician for ongoing and worsening symptoms of shingles, and at that encounter was diagnosed with post herpetic neuralgia, a chronic condition involving residual nerve pain and damage secondary to shingles. The patient was prescribed gabapentin and acyclovir for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the  patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Red, round itchy spots, bumps/rash on under arms, abdomen, lower abdomen, upper thighs, and lower legs. Very itchy, very inflamed. Lasted over two months, until treated with steroid injection, oral steroids, and topical steroids (on 6/25/21). A few areas left slight scarring. Also had some issues urinating. Had kidney scan on 6/22/21 and blood work on 6/7/21. Still investigating that issue. Apeear to have recoved fully from rash but treatment was completed recently (6/30/21).
Left upper arm along the midshaft of the arm there is a erythematous, mildly indurated patch elliptical in shape. The height from tip to tip 7 cm and width 4 cm. Patient complained it was itchy. It appears to be almost completely resolved.
I had a big red rash; I had a big red rash/ splotch on my left arm; fever; sore; Other vaccine same date product: Flu and Pneumonia shot administered on 01Oct2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Oct2022 at 11:00 as dose 1, single (Batch/Lot number: unknown) at the age of 56 years, in left arm for covid-19 immunisation; pneumococcal vaccine (PNEUMOCOCCAL VACCINE), on 01Oct2022 as unk unk, single (Batch/Lot number: unknown), in right arm for immunisation; influenza vaccine (INFLUENZA VACCINE), on 01Oct2022 as unk unk, single (Batch/Lot number: unknown), in left arm for immunisation. The patient's relevant medical history included: "Bone spur" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing); "Known allergies: sulfa drugs" (unspecified if ongoing), notes: Known allergies: sulfa drugs; "if covid prior vaccination: Yes" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: MELOXICAM; GLUCOSAMINE. The following information was reported: PRODUCT USE ISSUE (non-serious) with onset 01Oct2022, outcome "unknown", described as "Other vaccine same date product: Flu and Pneumonia shot administered on 01Oct2022"; RASH ERYTHEMATOUS (non-serious) with onset 02Oct2022 at 13:00, outcome "recovered", described as "I had a big red rash"; RASH MACULAR (non-serious) with onset 02Oct2022 at 13:00, outcome "recovered", described as "I had a big red rash/ splotch on my left arm"; PYREXIA (non-serious) with onset 02Oct2022 at 13:00, outcome "recovered", described as "fever"; PAIN (non-serious) with onset 02Oct2022 at 13:00, outcome "recovered", described as "sore". It was unknown if therapeutic measures were taken as a result of rash erythematous, rash macular, pyrexia, pain.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Nausea; Swollen arms; Itchiness; Dizzy; Tenderness; Redness; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arms), PRURITUS (Itchiness), DIZZINESS (Dizzy), TENDERNESS (Tenderness) and ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced TENDERNESS (Tenderness), ERYTHEMA (Redness) and VACCINATION SITE PAIN (Pain at injection site). On 11-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen arms), PRURITUS (Itchiness) and DIZZINESS (Dizzy). On 12-Apr-2021, the patient experienced NAUSEA (Nausea). On 03-Apr-2021, TENDERNESS (Tenderness) and VACCINATION SITE PAIN (Pain at injection site) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arms), PRURITUS (Itchiness), DIZZINESS (Dizzy), ERYTHEMA (Redness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was included prednisone 20 mg for five days and Mupirosin 2% ointment three times a day.  Company Comment: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
This spontaneous report was received from a registered nurse (who was also an immunization official) and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical histories, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported). There were no adverse effects reported. Administered doses of vaccines experienced an unspecified temperature excursion. It was not reported whether a data logger was involved or if there were previous temperature excursions. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1705USA014586:
Arms were red; Itching from shoulder to elbow; Broke out on arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arms were red), PRURITUS (Itching from shoulder to elbow) and RASH (Broke out on arm) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced ERYTHEMA (Arms were red), PRURITUS (Itching from shoulder to elbow) and RASH (Broke out on arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Arms were red), PRURITUS (Itching from shoulder to elbow) and RASH (Broke out on arm) outcome was unknown.            Concomitant product use was not provided by the reporter.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.
Blood pressure high, ache joints, high cholesterol, digestive problems, heart attack, stroke, rashes, diabetes.  7/6/07 Medical records accompanied report which reveal:  Pt experienced chest discomfort & was hospitalized 11/3-11/8/04.  2D echocardiogram revealed LVDF of 50%.  Myocardial perfusion spect test revealed global hypokinesis & LVDF of only 36%.  EKG showed non specific ST changes. FINAL DX: Acute coronary syndrome, uncontrolled HTN, reversible anterolateral perfusion defect secondary to stress induced ischemia. 7/27/07 Received medical records of 4/2005-7/2007 which reveal patient experienced hyperlipidemia, low back pain, NIDDM diagnosed around 11/04, HTN, LS spine disc disease, L5-S1 HNP w/left radiculopathy, DJD left hip & knee, hypothyroidism, cataracts, refractive vision error, OA, actinic keratosis skin lesions of both forearms.  Underwent PT for LBP & difficulty walking.  Patient had been followed by outside MD for 2 years prior.
Pt recvd MMR & devel swelling of eye lids; pt given DPH;
fever over 102  chills headache  passed out for approximately 30 seconds.   symptoms started 14 hours after administration
5-10 minute long seizure with cyanosis and postictal phase -- seizure began 12 hours after vaccination fever at time of seizure 101. Fever noted by parents prior to seizure.
Pt describes pruritus (generalized) lasting 5-6 days. Now localized to injection site and is lessening.
My arm and shoulder began to hurt after the first shot, worse after the 2nd shot and now I have adhesive capsulitis. (frozen shoulder.)